
Second-Line & Later Therapies Show Promising Outcomes in Small Cell Lung Cancer
Photo Credit: Mohammed Haneefa Nizamudeen Lurbinectedin showed clinical benefit across therapy lines in small cell lung cancer, with best responses seen in later lines and with prior immunotherapy exposure. According to research presented at ASCO 2025, …